635 related articles for article (PubMed ID: 17579925)
1. Tardive dyskinesia and glucid metabolism.
Brousse G; Meary A; Mouret J; Blanc O; Hueber T; Lemoine P; Llorca PM; Lachaux B
Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
[TBL] [Abstract][Full Text] [Related]
2. Tardive dyskinesia and impaired glucose tolerance.
Chong SA; Mythily ; Lum A; Huak CY; Kane J
Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
[TBL] [Abstract][Full Text] [Related]
3. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
Lee JG; Shin BS; Lee YC; Park SW; Kim YH
Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
[TBL] [Abstract][Full Text] [Related]
4. Does clozapine cause tardive dyskinesia?
Kane JM; Woerner MG; Pollack S; Safferman AZ; Lieberman JA
J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929
[TBL] [Abstract][Full Text] [Related]
5. [Utility of quetiapine in tardive dyskinesia].
Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
[TBL] [Abstract][Full Text] [Related]
6. Comparison of severe and mild tardive dyskinesia: implications for etiology.
Gardos G; Cole JO; Schniebolk S; Salomon M
J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
[TBL] [Abstract][Full Text] [Related]
7. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
Barnes TR
Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
Wolf ME; DeWolfe AS; Mosnaim AD
Hillside J Clin Psychiatry; 1987; 9(1):3-11. PubMed ID: 2888712
[TBL] [Abstract][Full Text] [Related]
9. Clinical and epidemiologic aspects of tardive dyskinesia.
Baldessarini RJ
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
[TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
Ezrin-Waters C; Seeman MV; Seeman P
J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia.
Souza RP; Remington G; Meltzer HY; Lieberman JA; Kennedy JL; Wong AH
Int Clin Psychopharmacol; 2010 Sep; 25(5):264-9. PubMed ID: 20436352
[TBL] [Abstract][Full Text] [Related]
12. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
Dean CE; Kuskowski MA; Caligiuri MP
J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
[TBL] [Abstract][Full Text] [Related]
13. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
[TBL] [Abstract][Full Text] [Related]
14. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
Kane JM
J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
[TBL] [Abstract][Full Text] [Related]
15. Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients.
Bailey LG; Maxwell S; Brandabur MM
Psychopharmacol Bull; 1997; 33(1):177-81. PubMed ID: 9133772
[TBL] [Abstract][Full Text] [Related]
16. [Tardive dyskinesia: pergolid, a possible therapeutic option].
Diehl A; Braus DF; Büchel C; Krumm B; Medori R; Gattaz WF
Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
[TBL] [Abstract][Full Text] [Related]
17. Historical perspective on movement disorders.
Friedman JH
J Clin Psychiatry; 2004; 65 Suppl 9():3-8. PubMed ID: 15189105
[TBL] [Abstract][Full Text] [Related]
18. Vulnerability to tardive dyskinesia.
Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of tardive dyskinesia in geropsychiatric outpatients.
Chacko RC; Root L; Marmion J; Molinari V; Adams GL
J Clin Psychiatry; 1985 Feb; 46(2):55-7. PubMed ID: 2857168
[TBL] [Abstract][Full Text] [Related]
20. Impaired glucose tolerance and abnormal movements in patients with schizophrenia.
Schultz SK; Arndt S; Ho BC; Oliver SE; Andreasen NC
Am J Psychiatry; 1999 Apr; 156(4):640-2. PubMed ID: 10200749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
